October 11, 2011 Private meeting

The October 11th Program was preceded by a private, exclusive CLOSED DOOR meeting with Arthur Tinklenberg, CEO of Enumeral who discussed the background and advantages of Enumeral’s platform technology in novel antibody discovery and quantitative immune profiling.
October 11 Program

Arthur